(Q37646545)

21 August 2017

1 reference

title

Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors (English)

1 reference

polymorphonuclear neutrophil

21 August 2017

main subject

0 references

3

Antonio Brú

1 reference

21 August 2017

Juan Carlos Souto

1

1 reference

21 August 2017

Luis Vila

series ordinal

2

1 reference

21 August 2017

publication date

1 May 2011

1 reference

Medicinal Research Reviews

21 August 2017

published in

1 reference

21 August 2017

volume

31

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

311-363

1 reference

Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments

21 August 2017

cites work

1 reference

Harnessing the immune system to treat cancer

21 January 2018

1 reference

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

Cancer-related inflammation

21 January 2018

1 reference

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

21 January 2018

1 reference

Novel trends in neutrophil structure, function and development

21 January 2018

1 reference

Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response

21 January 2018

1 reference

Peroxidase-mediated mammalian cell cytotoxicity

21 January 2018

1 reference

Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system

21 January 2018

1 reference

Cytotoxicity for tumor cells of cationic proteins from human neutrophil granules

21 January 2018

1 reference

Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide

21 January 2018

1 reference

Cytostasis of tumor cell lines by human granulocytes.

21 January 2018

1 reference

Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system

21 January 2018

1 reference

The analysis of cytostatic activity of human peripheral blood granulocytes and its augmentation with Nocardia rubra cell wall skeleton (N-CWS).

21 January 2018

1 reference

Participation of polymorphonuclear leukocyte-derived factor in murine tumour cell killing

21 January 2018

1 reference

Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes.

21 January 2018

1 reference

Inhibition of neutrophil-mediated cytotoxicity by exogenous adenosine 5'-triphosphate.

21 January 2018

1 reference

Cytostatic and tumoricidal activities of tumor necrosis factor-treated neutrophils

21 January 2018

1 reference

The mechanisms of cytotoxicity to tumor cells by polymorphonuclear leukocytes stimulated with cytokines.

21 January 2018

1 reference

Cytolytic heterogeneity of polymorphonuclear leukocytes in killing of murine tumor cells

21 January 2018

1 reference

Inhibition of macrophage- and neutrophil-mediated cytotoxicity by verapamil.

21 January 2018

1 reference

Inflammation and anti-tumor resistance. V. Production of a cytostatic factor following cooperation of elicited polymorphonuclear leukocytes and macrophages

21 January 2018

1 reference

Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).

21 January 2018

1 reference

Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium

21 January 2018

1 reference

Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs).

21 January 2018

1 reference

Visualization of oxidative processes at the cellular level during neutrophil‐mediated cytotoxicity against a human hepatoma cell line, HCC‐M

21 January 2018

1 reference

Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients.

21 January 2018

1 reference

Oxidative burst of neutrophils against melanoma B16-F10.

21 January 2018

1 reference

The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice

21 January 2018

1 reference

Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology

21 January 2018

1 reference

Murine granulocytes control human tumor growth in SCID mice.

21 January 2018

1 reference

Oxidative burst and anticancer activities of rat neutrophils

21 January 2018

1 reference

Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate

21 January 2018

1 reference

Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity.

21 January 2018

1 reference

Neutrophils in antibody-based immunotherapy of cancer

21 January 2018

1 reference

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

21 January 2018

1 reference

Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

21 January 2018

1 reference

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and az

21 January 2018

1 reference

Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity

21 January 2018

1 reference

Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G.

21 January 2018

1 reference

Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells

21 January 2018

1 reference

Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity

21 January 2018

1 reference

Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors

21 January 2018

1 reference

Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA.

21 January 2018

1 reference

CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils

21 January 2018

1 reference

Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16.

21 January 2018

1 reference

IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils

21 January 2018

1 reference

Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors.

21 January 2018

1 reference

Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma

21 January 2018

1 reference

Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model

21 January 2018

1 reference

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

21 January 2018

1 reference

Neutrophils in the antitumoral immune response

21 January 2018

1 reference

G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).

21 January 2018

1 reference

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo

21 January 2018

1 reference

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

21 January 2018

1 reference

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

21 January 2018

1 reference

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

21 January 2018

1 reference

Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13.

21 January 2018

1 reference

Direct killing of interleukin-2-transfected tumor cells by human neutrophils

21 January 2018

1 reference

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

21 January 2018

1 reference

Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response

21 January 2018

1 reference

Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer

21 January 2018

1 reference

IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity

21 January 2018

1 reference

IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice

21 January 2018

1 reference

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracrani

21 January 2018

1 reference

GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action

21 January 2018

1 reference

Lineage-specific hematopoietic growth factors

21 January 2018

1 reference

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

21 January 2018

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

21 January 2018

1 reference

Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration

21 January 2018

1 reference

A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

21 January 2018

1 reference

Constitutive expression of interleukin-8 by Mutatect cells markedly affects their tumor biology.

21 January 2018

1 reference

Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice

21 January 2018

1 reference

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

21 January 2018

1 reference

Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).

21 January 2018

1 reference

Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma

21 January 2018

1 reference

Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer

21 January 2018

1 reference

CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo

21 January 2018

1 reference

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

21 January 2018

1 reference

Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.

21 January 2018

1 reference

Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine

21 January 2018

1 reference

Bacteriolytic therapy can generate a potent immune response against experimental tumors

21 January 2018

1 reference

Cancer immunotherapy based on killing of Salmonella-infected tumor cells

21 January 2018

1 reference

Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy

21 January 2018

1 reference

Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma.

21 January 2018

1 reference

Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model.

21 January 2018

1 reference

Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

21 January 2018

1 reference

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

21 January 2018

1 reference

Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils

21 January 2018

1 reference

Role of neutrophils in BCG immunotherapy for bladder cancer

21 January 2018

1 reference

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

21 January 2018

1 reference

The role of granulocytes following intravesical BCG prophylaxis.

21 January 2018

1 reference

C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan

21 January 2018

1 reference

Development of TLR9 agonists for cancer therapy

21 January 2018

1 reference

Infection-mimicking materials to program dendritic cells in situ

21 January 2018

1 reference

Use of mild, whole body hyperthermia in cancer therapy.

21 January 2018

1 reference

A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models

21 January 2018

1 reference

Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia.

21 January 2018

1 reference

Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes

21 January 2018

1 reference

An important role for granulocytes in the thermal regulation of colon tumor growth

21 January 2018

1 reference

Spontaneous regression: a hidden treasure buried in time

21 January 2018

1 reference

Genetics of nonspecific immunity: I. Bidirectional selective breeding of lines of mice endowed with maximal or minimal inflammatory responsiveness.

21 January 2018

1 reference

Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis.

21 January 2018

1 reference

Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse.

21 January 2018

1 reference

Convergent alteration of granulopoiesis, chemotactic activity, and neutrophil apoptosis during mouse selection for high acute inflammatory response

21 January 2018

1 reference

Resistance to melanoma metastases in mice selected for high acute inflammatory response

21 January 2018

1 reference

Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response.

21 January 2018

1 reference

Genetic selection for high acute inflammatory response confers resistance to lung carcinogenesis in the mouse

21 January 2018

1 reference

Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness.

21 January 2018

1 reference

Spontaneous regression of advanced cancer: Identification of a unique genetically determined, age-dependent trait in mice

21 January 2018

1 reference

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

21 January 2018

1 reference

Photodynamic therapy and anti-tumour immunity.

21 January 2018

1 reference

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy

21 January 2018

1 reference

Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors

21 January 2018

1 reference

Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF

21 January 2018

1 reference

Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma

21 January 2018

1 reference

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors

21 January 2018

1 reference

Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils

21 January 2018

1 reference

Role of cytokines in photodynamic therapy-induced local and systemic inflammation

21 January 2018

1 reference

Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors

21 January 2018

1 reference

Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy

21 January 2018

1 reference

Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma

21 January 2018

1 reference

Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors

21 January 2018

1 reference

Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator

21 January 2018

1 reference

Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases.

21 January 2018

1 reference

PMN cells from chronic myeloid leukemia (CML) patients show defective chemotaxis in remission

21 January 2018

1 reference

Leukocyte function in children with malignancies

21 January 2018

1 reference

Spontaneous and stimulated nitroblue tetrazolium tests of leukocytes from patients with solid malignant tumors

21 January 2018

1 reference

Superoxide anion-generating activity of polymorphonuclear leukocytes and monocytes in patients with lung cancer

21 January 2018

1 reference

Granulocyte activity in patients with cancer and healthy subjects

21 January 2018

1 reference

Differences between the activities of mature granulocytes in leukemic and normal blood

21 January 2018

1 reference

Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment

21 January 2018

1 reference

Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer.

21 January 2018

1 reference

Defective Neutrophil Function in Chronic Granulocytic: Leukaemia

21 January 2018

1 reference

Neutrophil function during chemotherapy for Hodgkin's disease

21 January 2018

1 reference

Serum-associated inhibition of leukotaxis in humans with cancer

21 January 2018

1 reference

Impairment of neutrophil chemotaxis by serum from patients with chronic lymphoproliferative disease

21 January 2018

1 reference

Inhibition of candidacidal activity of polymorphonuclear cells by alveolar macrophage-derived factor from lung cancer patients

21 January 2018

1 reference

Changes in superoxide anion production and phagocytosis by circulating neutrophils during tumor progression in a rat model.

21 January 2018

1 reference

Functions of salivary polymorphonuclear leukocytes (SPMNs) and peripheral blood polymorphonuclear leukocytes (PPMNs) from healthy individuals and oral cancer patients.

21 January 2018

1 reference

Neutrophil function in lymphoreticular malignancy

21 January 2018

1 reference

Phagocytes as carcinogens: malignant transformation produced by human neutrophils.

21 January 2018

1 reference

Tumorigenic conversion of a rat urothelial cell line by human polymorphonuclear leukocytes activated by lipopolysaccharide

21 January 2018

1 reference

Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells

21 January 2018

1 reference

Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium

21 January 2018

1 reference

The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.

21 January 2018

1 reference

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression

21 January 2018

1 reference

Inhibition of tumor growth by elimination of granulocytes

21 January 2018

1 reference

Containment of tumor-colonizing bacteria by host neutrophils.

21 January 2018

1 reference

In vivo Tumor Growth Enhancement by Granulocyte Colony-stimulating Factor

21 January 2018

1 reference

alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro

21 January 2018

1 reference

Immunochemotherapy in human lung cancer using the streptococcal agent OK-432

21 January 2018

1 reference

Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.

21 January 2018

1 reference

Super-Rough Dynamics on Tumor Growth

21 January 2018

1 reference

The universal dynamics of tumor growth

21 January 2018

1 reference

Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): a model for human lung cancer

21 January 2018

1 reference

Pinning of Tumoral Growth by Enhancement of the Immune Response

21 January 2018

1 reference

Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.

21 January 2018

1 reference

Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

21 January 2018

1 reference

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines

21 January 2018

1 reference

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms

21 January 2018

1 reference

Inflammatory chemokines in cancer growth and progression

21 January 2018

1 reference

Chemokines in tumor progression and metastasis

21 January 2018

1 reference

21 January 2018

Hereditary neutrophilia.

1 reference

The immunologic constant of rejection

21 January 2018

1 reference

Non-activated rat neutrophils kill syngeneic colon tumor cells by the release of a low molecular weight factor

21 January 2018

1 reference

In vivoinduction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF)

21 January 2018

1 reference

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.20185

1 reference

21 August 2017

1 reference